[1] BATTIPROLUPK, LOPEZ-CRISOSTOC, WANG ZV, et al.Diabetic cardiomyopathy and metabolic remodeling of the heart[J].Life Sci, 2013, 92(11):609. doi: 10.1016/j.lfs.2012.10.011
[2] FALCÃO-PIRES I, LEITE-MOREIRA F.Diabetic cardiomyopathy:understanding the molecular and cellular basis to progress in diagnosis and treatment[J].Heart Fail Rev, 2012, 17(3):325. doi: 10.1007/s10741-011-9257-z
[3] 彭海兵, 曹福源, 王建行, 等.熊果酸对矽肺大鼠TNF-α和胶原合成的调节作用[J].卫生研究, 2014, 43(4):594.
[4] 张新华, 朱萱.熊果酸药理学的最新研究进展[J].中国中西医结合杂志, 2011, 31(9):1285.
[5] 张杰, 吴淑艳, 王琳, 等.熊果酸对胰岛素抵抗大鼠肝脏组织PTP-1B, IRS-2mRNA表达的影响[J].江苏中医药, 2010, 42(4):69. doi: 10.3969/j.issn.1672-397X.2010.04.044
[6] 齐敏友, 杨钧杰.熊果酸对糖尿病小鼠肾病的保护作用及机制研究[J].中国应用生理学杂志, 2014, 30(5):445.
[7] RUBLER S, DLUGASH J, YUCEOGLU YZ, et al.New type of cardiomyopathy associated with diabetic glomerulosclerosis[J].Am J Cardiol, 1972, 30(6):595. doi: 10.1016/0002-9149(72)90595-4
[8] COYAL BR, MEHTA AA.Diabetic cardiomyopathy:pathophysiological mechanisms and cardiac dysfunction[J].Hum Exp Toxicol, 2013, 32(6):571. doi: 10.1177/0960327112450885
[9] 潘柏申, 杨振华, 吴建民.冠状动脉疾病和心力衰竭时心脏标志物临床检测应用建议[J].中华检验医学杂志, 2006, 9(29):774.
[10] 范维唬, 赵碧莲.心肌损伤标志物在急胜冠脉综合征的应用[J].中国实用内科杂志, 2008, 28(1):16. doi: 10.3969/j.issn.1005-2194.2008.01.008
[11] 胡晓琳, 干余良.心肌捐伤标志物发其联合粉测的临床意义[J].国外医学:临床生物化学与检验学分册, 2001, 6(22):297.
[12] 刘恩华, 陈坏敏, 孔丽清, 等.急性心肌梗死病人心肌损伤标志物动态监测价值的比较[J].标记免疫分析与临床, 2010, 17(2):65. doi: 10.3969/j.issn.1006-1703.2010.02.001
[13] 朱蕾, 董梅, 吴纯, 等.急性脑血管病病人心肌酶谱监测及临床意义研究[J].现代检验医学杂志, 2008, 1(13):93.
[14] PARK TS, HU Y, NOH HL, et al.Ceramide is a cardiotoxin in lipotoxic cardiomyopathy[J].J Lipid Res, 2008, 49(10):2101. doi: 10.1194/jlr.M800147-JLR200
[15] MANDRUP-POULSEN T.Apoptotic signal transduction pathways in diabetes[J].Biochem Pharmacol, 2003, 66(8):1433. doi: 10.1016/S0006-2952(03)00494-5